These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8693501)
1. Infection by hepatitis C virus through contaminated intravenous immune globulin: results of a prospective national inquiry in France. Lefrère JJ; Loiseau P; Martinot-Peignoux M; Mariotti M; Ravera N; Thauvin M; Marcellin P; Janot C Transfusion; 1996 May; 36(5):394-7. PubMed ID: 8693501 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. Bjøro K; Frøland SS; Yun Z; Samdal HH; Haaland T N Engl J Med; 1994 Dec; 331(24):1607-11. PubMed ID: 7526215 [TBL] [Abstract][Full Text] [Related]
3. Transmission of hepatitis C virus in allografted patients: use of viral genotyping as an epidemiological marker. Gangneux JP; Traineau R; Tuveri R; Ravera N; Bureau C; Gluckman E; Benbunan M; Loiseau P Bone Marrow Transplant; 1996 Dec; 18(6):1131-3. PubMed ID: 8971383 [TBL] [Abstract][Full Text] [Related]
4. Laboratory diagnosis and molecular epidemiology of an outbreak of hepatitis C virus infection among recipients of human intravenous immunoglobulin in Spain. Echevarría JM; León P; Domingo CJ; López JA; Elola C; Madurga M; Salmerón F; Yap PL; Daub J; Simmonds P Transfusion; 1996 Aug; 36(8):725-30. PubMed ID: 8780668 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. Bresee JS; Mast EE; Coleman PJ; Baron MJ; Schonberger LB; Alter MJ; Jonas MM; Yu MY; Renzi PM; Schneider LC JAMA; 1996 Nov; 276(19):1563-7. PubMed ID: 8918853 [TBL] [Abstract][Full Text] [Related]
6. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Healey CJ; Sabharwal NK; Daub J; Davidson F; Yap PL; Fleming KA; Chapman RW; Simmonds P; Chapel H Gastroenterology; 1996 Apr; 110(4):1120-6. PubMed ID: 8613001 [TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of hepatitis C virus RNA in immune globulins. Yu MY; Mason BL; Tankersley DL Transfusion; 1994 Jul; 34(7):596-602. PubMed ID: 7519795 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus RNA in tetanus intramuscular immune globulin. Pisani G; Cristiano K; Wirz M; Pini C; Gentili G Transfusion; 1997 Sep; 37(9):986-7. PubMed ID: 9308652 [No Abstract] [Full Text] [Related]
9. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Rossi G; Tucci A; Cariani E; Ravaggi A; Rossini A; Radaeli E Blood; 1997 Aug; 90(3):1309-14. PubMed ID: 9242566 [TBL] [Abstract][Full Text] [Related]
10. At least three hepatitis C virus strains implicated in Swedish and Danish patients with intravenous immunoglobulin-associated hepatitis C. Widell A; Zhang YY; Andersson-Gäre B; Hammarström L Transfusion; 1997 Mar; 37(3):313-20. PubMed ID: 9122906 [TBL] [Abstract][Full Text] [Related]
11. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Jonas MM; Baron MJ; Bresee JS; Schneider LC Pediatrics; 1996 Aug; 98(2 Pt 1):211-5. PubMed ID: 8692620 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin and hepatitis C virus: the Scandinavian experience. Björkander J; Fasth A; Widell A Clin Ther; 1996; 18 Suppl B():73-82. PubMed ID: 8930444 [TBL] [Abstract][Full Text] [Related]
13. HCV infection in patients with primary defects of immunoglobulin production. Quinti I; Pandolfi F; Paganelli R; el Salman D; Giovannetti A; Rosso R; Oliva A; Rainaldi L; Aiuti F Clin Exp Immunol; 1995 Oct; 102(1):11-6. PubMed ID: 7554376 [TBL] [Abstract][Full Text] [Related]
15. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission. Berger A; Doerr HW; Scharrer I; Weber B J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728 [TBL] [Abstract][Full Text] [Related]
16. Low rate of HCV transmission from women infected with contaminated anti-D immunoglobulin to their family contacts. Sachithanandan S; Fielding JF Ital J Gastroenterol Hepatol; 1997 Feb; 29(1):47-50. PubMed ID: 9265578 [TBL] [Abstract][Full Text] [Related]
17. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. Krawczynski K; Alter MJ; Tankersley DL; Beach M; Robertson BH; Lambert S; Kuo G; Spelbring JE; Meeks E; Sinha S; Carson DA J Infect Dis; 1996 Apr; 173(4):822-8. PubMed ID: 8603959 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in hypogammaglobulinemic patients receiving long-term replacement therapy with intravenous immunoglobulin. Taliani G; Guerra E; Rosso R; Badolato MC; Luzi G; Sacco G; Lecce R; De Bac C; Aiuti F Transfusion; 1995 Feb; 35(2):103-7. PubMed ID: 7825204 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus transmission by intravenous immunoglobulin. Farrugia A; Walker E Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718 [No Abstract] [Full Text] [Related]
20. Prevalence of hepatitis C in patients with primary antibody deficiency. Webster AD; Brown D; Franz A; Dusheiko G Clin Exp Immunol; 1996 Jan; 103(1):5-7. PubMed ID: 8565286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]